Surely all of the Facebook virus experts calling for heard immunity figured on virus mutations right?There's a new variant out of Brazil. This one looks like it could be vaccine resistant and it also looks like it could re-infect people who got a different variant of the disease earlier. It also spreads rapidly.
"If you were to ask me right now, what's most concerning of all the things that I've heard so far, it's the fact that they are reporting a sudden increase in cases in Manaus, Brazil," virus expert Jeremy Luban at the University of Massachusetts told NPR two weeks ago before the variant arrived in the United States. "Manaus already had 75% of people infected [in the spring of last year]."
The concern with P.1 is twofold: Scientists don't understand why the variant has spread so explosively in Brazil, and the variant carries a particularly dangerous set of mutations.
While the variant from the U.K. took about three months to dominate the outbreak in England, P.1 took only about a month to dominate the outbreak in Manaus. In addition, Manaus had already been hit extremely hard by the virus in April. One study estimated that the population should have reached herd immunity and the virus shouldn't be able to spread easily in the community. So why would the city see an even bigger surge 10 months later? Could P.1 be evading the antibodies made against the previous version of the virus, making reinfections easier? Could it just be significantly more contagious? Could both be true?
Why Scientists Are Very Worried About The Variant From Brazil
They don't yet understand why the coronavirus variant called P.1 has spread so explosively there. Its set of mutations seem especially dangerous. And this week P.1 was confirmed in the U.S.www.npr.org
This is a better article that defines all the mutations of interest and gives stats on each regarding vaccine efficacy and how easily they spread.
Coronavirus variants: What they do and how worried you should be
The Ars guide to the coronavirus variantsarstechnica.com
And a potential new treatment! Mouse studies look promising.
SARS-CoV-2 viral proteins interact with the eukaryotic translation machinery and inhibitors of translation have potent antiviral effects. Here we report that the drug plitidepsin (aplidin), which has limited clinical approval, possesses antiviral activity (IC90 = 0.88 nM) 27.5-fold more potent than remdesivir against SARS-CoV-2 in vitro, with limited toxicity in cell culture. Through the use of a drug resistant mutant, we show that the antiviral activity of plitidepsin against SARS-CoV-2 is mediated through inhibition of the known target eEF1A. We demonstrate the in vivo efficacy of plitidepsin treatment in two mouse models of SARS-CoV-2 infection with a reduction of viral replication in the lungs by two orders of magnitude using prophylactic treatment. Our results indicate that plitidepsin is a promising therapeutic candidate for COVID-19.
AAAS
science.sciencemag.org
I remember being introduced to this problem when I was working for child special health services. We had a ton of problems finding parents reliable transportation to their children's appointments. I encountered this same problem again when working in private insurance with dialysis patients. Many of our dialysis patients would call an ambulance to get them to their appointment. One big problem we had in both communities was that there was the potential of large chairs or other mobility aides that might not always be able to be accommodated by a taxi or uber. Other problems included them relying on someone else for rides that couldn't make it, getting off of work to get to an appointment (or your ride getting off of work), and finding the money to pay for the ride. The assumption that people can get to appointments is a huge, and largely unrealistic assumption when you are talking about a large metro area. I hate it when people who don't have a background in community health are put in charge of community health initiatives like this. This is a huge oversight that anyone who has ever worked with low income communities wouldn't make.This leads to another issue. Transportation. Many seniors don't have cars, don't drive or only drive locally. Not to mention many vaccination clinics require you to wait in your car until it is time for your appointment.
It really has been a nightmare. Every one of my friends has had to do the legwork to get their parents appointments. And these are 75-80 year olds who use the internet in their daily lives. I cannot imagine the older crowds.The vaccine rollout for seniors has been a complete shit show here in Massachusetts.
My dad was able to get his last week which is a huge relief for me since he's a transplant patient. My mom couldn't get hers yet.It really has been a nightmare. Every one of my friends has had to do the legwork to get their parents appointments. And these are 75-80 year olds who use the internet in their daily lives. I cannot imagine the older crowds.
My in-laws in Kentucky both had their first vaccine last week. I'm not sure what their registration process was like in KY, but over Thanksgiving I spent 30 minutes (unsuccessfully) explaining the difference between internet and wifi to my mother-in-law, so it couldn't have been too difficult!
All that said, my parents are supposed to get their vaccine this afternoon. Hopefully this snow holds off.